Welcome to LookChem.com Sign In|Join Free
  • or
2,4-di-tert-butyl-6-(N-methylamino)phenol, also known as butylated hydroxyanisole (BHA), is a synthetically derived chemical compound that belongs to the class of phenolic antioxidants. It is widely used as a food additive to prevent oxidation and spoilage, thereby extending the shelf life of various food products. BHA is particularly effective in preserving oils, fats, and food products with high fat content. The compound is also used in industrial applications, such as rubber and petroleum products, to prevent oxidative degradation. Despite its benefits, BHA has been a subject of debate due to potential health concerns, and its use is regulated by various food safety authorities. It is important to note that the safety and usage levels of BHA are strictly monitored to ensure that it does not pose a risk to human health when used within the prescribed limits.

1085-21-8

Post Buying Request

1085-21-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1085-21-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1085-21-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,8 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1085-21:
(6*1)+(5*0)+(4*8)+(3*5)+(2*2)+(1*1)=58
58 % 10 = 8
So 1085-21-8 is a valid CAS Registry Number.

1085-21-8Downstream Products

1085-21-8Relevant academic research and scientific papers

Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases

-

, (2015/09/22)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES

-

, (2012/04/23)

The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1085-21-8